Lemonade Inc (LMND)
Who owns Lemonade Inc (LMND)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 92.7% of the shares are freely tradable; institutional investors hold 59.7%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| JPMorgan Chase & Co | 6.81 | 5,262,816 | +17.4 | 03/31/2026 |
| BlackRock Inc | 6.43 | 4,968,901 | +0.4 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.90 | 3,018,092 | +0.0 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 3.86 | 2,981,857 | +0.0 | 03/31/2026 |
| Baillie Gifford & Co Limited. | 3.58 | 2,766,426 | -3.5 | 03/31/2026 |
| Geode Capital Management, LLC | 2.22 | 1,715,851 | +19.3 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Morn Total Stk Mkt Idx Investor | 2.84 | 2,193,559 | +0.3 | 06/30/2026 |
| iShares Russell 2000 ETF | 2.40 | 1,854,794 | -0.1 | 07/30/2026 |
| Vanguard US Growth Investor | 2.20 | 1,702,275 | +0.0 | 06/30/2026 |
| Vanguard Small Cap Index | 2.05 | 1,585,889 | +0.3 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 27. Jul 2026 | Peters John Sheldon | Chief Insurance Officer | Other | 10,000 | 0.00 | – |
| 7. Jul 2026 | Bixby Timothy E | Chief Financial Officer | Sell | 73,000 | 79.18 | 5,780,140 |
| 6. Jul 2026 | Peters John Sheldon | Chief Insurance Officer | Sell | 3,444 | 79.00 | 272,076 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.